Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04189471 · ClinicalTrials.gov registry record

Improving Outcomes for Patients With Life-Threatening Neurologic Illness

A clinical trial of Intracerebral Hemorrhage and Subarachnoid Hemorrhage, sponsored by University of Maryland, Baltimore.

Recruiting
Registry status
5,000
Enrollment target
1
Study location

NCT04189471: Recruiting study of Intracerebral Hemorrhage and Subarachnoid Hemorrhage, sponsored by University of Maryland, Baltimore.

NCT04189471 is a study of Intracerebral Hemorrhage and Subarachnoid Hemorrhage that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 5,000 participants, above the 945-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (429% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04189471, a study of Intracerebral Hemorrhage and Subarachnoid Hemorrhage, is actively recruiting participants, sponsored by University of Maryland, Baltimore.

RECRUITING
Registry status
5,000 participants
Enrollment target
1
Study location

Study Summary

Background: While the intensive care of patients with life-threatening brain illnesses has advanced tremendously, a large number of therapies are still without proper scientific support. This can be partly explained by the fact that mechanisms of initial brain injury are still not well understood. Why additional neurological injury occurs during a patient's stay in the NeuroCritical Care Unit (NCCU) despite current best, evidence-based clinical practices, is also not well understood. However, over the past decade, better tools have become available to measure and monitor the impact of our clinical care on the rapidly changing physiology and chemistry of the injured brain. Some of these tools are CT, MRI, ultrasound, and catheter-based technology measuring blood flow and metabolism. These tools have enabled earlier detection of injury and complications and newer therapeutic strategies. Purpose: Examine disease pathways common to all brain injuries seen in the University of Maryland's 22-bed NCCU. Life-threatening neurological illnesses cared for in the NCCU include massive stroke, bleeding in and around the brain (subarachnoid hemorrhage, intracerebral hemorrhage, subdural hemorrhage, intraventricular hemorrhage), brain tumors, difficult to control seizures, neurologic infections, nerve and muscle diseases (such as myasthenia gravis or Guillain-Barre Syndrome), and spinal cord disorders among others. Many NCCU patients are comatose or paralyzed and may suffer injuries in other parts of the body as well. This effort will require the creation of a robust clinical database for the capture of data including patient characteristics (age, sex), clinical characteristics, medical treatments, surgical interventions, physiological data (such as vital signs, cerebral blood flow, intracranial pressure, cerebral oximetry, etc), laboratory data, and standard-of-care diagnostic studies such as electroencephalography (EEG), ultrasound, CT, MRI, and angiograms. Similar databases

Primary Outcome

The Barthel scale is an ordinal scale used to measure performance in activities of daily living. Scores range from 0 to 100. A higher score signifies better outcomes, more independent functionality.

Study Locations (1)

Maryland

  • University of Maryland Medical Center - Baltimore

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2014-09-08
Est. Completion 2034-01-01
University of Maryland, Baltimore

560 total trials

What NCT04189471 shows while recruiting

NCT04189471 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 945-participant average among 31 other Intracerebral Hemorrhage trials with a reported enrollment target (429% higher).

The record links to 5 conditions, with Intracerebral Hemorrhage appearing as the primary indexed condition, and to 0 interventions.

NCT04189471 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT04189471 about?

NCT04189471 is a clinical study titled "Improving Outcomes for Patients With Life-Threatening Neurologic Illness". Background: While the intensive care of patients with life-threatening brain illnesses has advanced tremendously, a large number of therapies are still without proper scientific support. This can be partly explained by the fact that mechanisms of initial brain injury are still not well understood....

What is the current status of trial NCT04189471?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2014-09-08. Estimated completion is 2034-01-01.

What conditions does trial NCT04189471 study?

This clinical trial studies the following conditions: Intracerebral Hemorrhage, Subarachnoid Hemorrhage, Intraventricular Hemorrhage, Status Epilepticus, Nontraumatic Haemorrhage.

Who is sponsoring clinical trial NCT04189471?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04189471 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intracerebral Hemorrhage

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04189471's enrollment target sits among peer trials

5,000 3rd of 31 higher than 29 of 31 other Intracerebral Hemorrhage trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Intracerebral Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00060541 · 5,000 participants

    Evaluation and Treatment of Neurosurgical Disorders

  • NCT00575081 · 5,000 participants

    Physiological Brain Atlas Development

  • NCT00736749 · 5,000 participants

    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

  • NCT00900198 · 5,000 participants

    Collection of Tissue Samples for Cancer Research

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04189471, the US trial registry maintained by the National Library of Medicine. NCT04189471 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.